© 2024 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Latest Conference Articles
Study Shows Variations in RWE Citation Frequency
Skylar Jeremias
May 20 2020
Real world evidence (RWE) was cited differently depending on a number of criteria, leaving the door open to future research on how RWE influences payer decision making for specialty drug plans, said presenting author, Ari Panzer, at the Virtual ISPOR 2020, the annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
ISPOR Panelists Weigh the Success of APMs
Tony Hagen
May 19 2020
The alternative payment model (APM) doesn’t perfectly balance the competing interests of revenue growth and value-based care, but it has been a learning tool, panelists said at Virtual ISPOR 2020, the annual meeting of the International Society for Pharmacoeconomics and Outcomes Research.
Panelists Advocate for Global Collaboration in RWE Effort
Skylar Jeremias
May 19 2020
Harmonized efforts across global borders and among stakeholders are needed to generate and build acceptance of real world evidence (RWE) to actively aid in health care decision making, panelists said at Virtual ISPOR 2020, the annual meeting of the International Society for Pharmacoeconomics and Outcomes Research.
International Reference Pricing Gets Thumbs-Down From ISPOR Panel
Tony Hagen
May 18 2020
There’s not enough study of the effects of international reference pricing, but it is likely to stifle innovation and create access problems, according to an expert panel at Virtual ISPOR 2020, the annual meeting of the International Society for Pharmacoeconomics and Outcomes Research.
AMCP, ACHP Advocate for Health Care Improvements
Skylar Jeremias
May 15 2020
Pharmacy organizations such as the Academy of Managed Care Pharmacy (AMCP) and the Alliance of Community Health Plans (ACHP) are advocating for structural changes to health care based on lessons learned from the coronavirus disease 2019 (COVID-19) pandemic.
Pharmacies Rise to the Challenges Imposed by COVID-19
Skylar Jeremias
May 14 2020
In light of the coronavirus disease 2019 (COVID-19) pandemic, pharmacies have implemented new strategies to ensure their patients continue to receive care, especially for those who have lost their insurance or have underlying conditions.
